Octreotide extended-release (LF-PB)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Octreotide extended-release (LF-PB), covering 2017-02-02 to 2017-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Extended-release of Octreotide (LF-PB) for the Treatment of Seroma [Phase 2]